+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Lewy body Dementia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767695
  • Report
  • April 2019
  • Region: Global
  • 61 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Arena Pharmaceuticals Inc
  • ATP Clinical Research
  • Eisai Co Ltd
  • GlaxoSmithKline Plc
  • Roivant Sciences Ltd
  • Sumitomo Chemical Co Ltd
  • MORE
The global clinical trial report- “2019 Lewy body Dementia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Lewy body Dementia. It presents in-depth analysis of Lewy body Dementia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Lewy body Dementia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Lewy body Dementia clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Lewy body Dementia

The research work is prepared through extensive and continuous research on Lewy body Dementia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Lewy body Dementia patients are identified
  • The report includes panorama of Lewy body Dementia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Lewy body Dementia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Arena Pharmaceuticals Inc
  • ATP Clinical Research
  • Eisai Co Ltd
  • GlaxoSmithKline Plc
  • Roivant Sciences Ltd
  • Sumitomo Chemical Co Ltd
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Lewy body Dementia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Lewy body Dementia Clinical Trials by Region
2.2.2 Average Enrollment of Lewy body Dementia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Lewy body Dementia Treatment, 2019

3. Region wise Lewy body Dementia Clinical Trials
3.1 Asia Pacific Lewy body Dementia Clinical Trials by Country
3.2 Europe Lewy body Dementia Clinical Trials by Country
3.3 North America Lewy body Dementia Clinical Trials by Country
3.4 Middle East and Africa Lewy body Dementia Clinical Trials by Country
3.5 South and Central America Lewy body Dementia Clinical Trials by Country

4. Lewy body Dementia Clinical Trial Trends
4.1 Start Year wise Lewy body Dementia Clinical Trials
4.2 Phase wise Lewy body Dementia Clinical Trials
4.3 Trial Status wise Lewy body Dementia Clinical Trials
4.4 Trial Type wise Lewy body Dementia Clinical Trials

5. Lewy body Dementia Average Enrollment Trends
5.1 Average Enrollment in Lewy body Dementia Trials by Year
5.2 Average Enrollment in Lewy body Dementia Trials by Phase
5.3 Average Enrollment in Lewy body Dementia Trials by Status
5.4 Average Enrollment in Lewy body Dementia Trials by Type of Trial

6. Companies Participating in Lewy body Dementia Clinical Trials
6.1 Lewy body Dementia Trials by Sponsor Type
6.2 Lewy body Dementia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Lewy body Dementia Trials- Phase 1
7.2 Lewy body Dementia Trials- Phase 2
7.3 Lewy body Dementia Trials- Phase 3
7.4 Lewy body Dementia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Lewy body Dementia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Lewy body Dementia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Lewy body Dementia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Lewy body Dementia Clinical Trials and Enrolment
Figure 7: North America - Country wise Lewy body Dementia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Lewy body Dementia Clinical Trials and Enrolment
Figure 9: Lewy body Dementia Clinical Trials by Phase
Figure 10: Lewy body Dementia Clinical Trials by Trial Status
Figure 11: Lewy body Dementia Clinical Trials by Type
Figure 12: Lewy body Dementia Clinical Trials by Sponsor Type
Figure 13: Lewy body Dementia Clinical Trials by Leading Sponsors
Figure 14: Lewy body Dementia Average Enrollment by Phase
Figure 15: Lewy body Dementia Average Enrollment by Trial Status
Figure 16: Lewy body Dementia Average Enrollment by Type
Figure 17: Lewy body Dementia- Average Enrolment by Type of Sponsors
Figure 18: Lewy body Dementia- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Lewy body Dementia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Lewy body Dementia Clinical Trials and Enrolment
Table 5: Europe - Country wise Lewy body Dementia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Lewy body Dementia Clinical Trials and Enrolment
Table 7: North America - Country wise Lewy body Dementia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Lewy body Dementia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Lewy body Dementia Average Enrollment by Phase
Table 15: Lewy body Dementia Average Enrollment by Trial Status
Table 16: Lewy body Dementia Average Enrollment by Type
Table 17: Lewy body Dementia- Average Enrolment by Type of Sponsors
Table 18: Lewy body Dementia- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • Acadia Pharmaceuticals Inc
  • Arena Pharmaceuticals Inc
  • ATP Clinical Research
  • Eisai Co Ltd
  • GlaxoSmithKline Plc
  • Roivant Sciences Ltd
  • Sumitomo Chemical Co Ltd
  • Teva Pharmaceutical Industries Ltd
  • The Lundbeck Foundation
  • Tsumura & co
Note: Product cover images may vary from those shown
Adroll
adroll